Pharma Giant Bayer’s $100M Quality Control Facility Complete
The new facility at its Berkeley campus will be critical to ensuring that treatments produced are safe and effective.
East Bay Times:
Berkeley: Bayer Completes $100 Million Quality Control Unit
The Bayer Corp. has announced the completion of a new, $100 million quality control facility at its Berkeley campus that will help develop the company’s Next Generation Hemophilia Treatments and other future products. The international pharmaceutical giant will show political dignitaries and members of the news media around the new facility on July 13. Mayor Jesse Arreguin and Bayer leaders are expected to make speeches. Also expected to attend is Panorea Advis, director of the California Governor’s Office of Business and Economic Development. Bayer leaders expected to attend include Joerg Heidrich, the Berkeley site head, and Tina Self, vice president of quality for Supply Center Berkeley. (Lochner, 7/5)
In other pharmaceutical news —
Sales Of Drugs For Diabetes Are Increasing Nationally
The pharma exhibits at the American Diabetes Association conference here last month stretched across the San Diego Convention Center floor like a mile of drugs. Displays for Tresiba, Invokana and Victoza, to name just a few, conveyed the largesse of an industry that is skyrocketing by any measure: dollar cost per unit, the number of people purchasing them and the number of prescriptions sold. (Clarke, 7/5)